PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Yufang Chen

Fujian Medical University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · JOURNAL ARTICLE

InterfaciallyEngineered Hafnium-Doped Hollow PrussianBlue Nanoreactors for Hypoxia-Relieved Synergistic Radio-Chemo-PhotothermalTherapy

Bioconjugate Chemistry

This is a preclinical in vivo proof-of-concept study of a novel nanoparticle platform in mice; it demonstrates mechanistic feasibility but lacks clinical translation, efficacy comparators, or human data needed to guide clinical practice.

Hypothesis-Generating洪超韦 Baohui Liu Nanoparticle-based Drug Delivery

Reported

Tumor model4T1

Apparent systemic toxicitynone reported

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support